XYL
58
6
CMG
54
4
HAS
57
2
JCI
54
2
KO
47
-5
GPC
51
13
AMT
55
-3
HST
57
5
HP
45
4
MKC
59
-3
XRX
55
3
MAT
54
3
PX
56
4
BK
74
2
MRK
50
-3
XEL
62
-3
FLS
59
13
R
70
4
ICE
62
-2
AVGO
49
9
XYL
58
6
CMG
54
4
HAS
57
2
JCI
54
2
KO
47
-5
GPC
51
13
AMT
55
-3
HST
57
5
HP
45
4
MKC
59
-3
XRX
55
3
MAT
54
3
PX
56
4
BK
74
2
MRK
50
-3
XEL
62
-3
FLS
59
13
R
70
4
ICE
62
-2
AVGO
49
9
Financhill
Back

Seelos Therapeutics 10K Form

Sell
7

SEEL
Seelos Therapeutics

Last Price:
0.20
Seasonality Move:
-10.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SEEL News And Ratings

See the #1 stock for the next 7 days that we like better than SEEL

SEEL Financial Statistics

Sales & Book Value

Annual Sales: $4.84M
Cash Flow: $-972K
Price / Cash Flow: 0
Annual Sales: $-8.47
Price / Book: 0

Profitability

EPS (TTM): -29.72000
Net Income (TTM): $4.09M
Gross Margin: $3.92M
Return on Equity: 0%
Return on Assets: 0%

Seelos Therapeutics Earnings Forecast

Key Seelos Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 17 years for SEEL is 80.95%.
  • The Selling, General & Administrative Expenses for SEEL have been equal to 217.32% of Gross Profit Margin.
  • The Interest Expense is -0.20% of Operating Income.
  • Per Share Earnings over the last 27 years have been positive in 17 years.

Seelos Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SEEL
CUSIP: 81577F
Website: seelostherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SEEL Technical Analysis vs Fundamental Analysis

Sell
7
Seelos Therapeutics (SEEL) is a Sell

Is Seelos Therapeutics a Buy or a Sell?